Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

$24.99

Price to Sales (P/S)
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Elevance Health Inc., P/S, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Elevance Health Inc. Annual Report.


Share Price Trend
The share price exhibited significant volatility over the analyzed period. Initially fluctuating moderately between roughly $41 and $87 per share from 2006 to 2014, the price saw notable increases during 2014 to 2018, reaching a peak above $300 by 2019. After 2019, the share price showed a sharp rise to nearly $460 in 2022 but then experienced a dramatic and likely anomalous spike in 2023 to an extremely high level, followed by a corrected value closer to $500 in 2024 and a subsequent decline to approximately $390 by 2025. This anomaly suggests potential irregularities or data errors at that point.
Sales Per Share Development
Sales per share demonstrated a consistent upward trend throughout the entire period under review. Starting from approximately $68 in 2006, sales per share increased steadily year over year without any significant downturns, eventually surpassing $770 by 2025. This progression indicates strong growth in the company's revenue generation on a per share basis, suggesting enhanced operational performance or expansion of business activities over time.
Price-to-Sales (P/S) Ratio Analysis
The P/S ratio displayed a declining trend in the initial years, dropping from 1.14 in 2006 to a low of 0.31 around 2013, indicating the share price was moving lower relative to sales per share during this time. Following this trough, the ratio experienced moderate fluctuations but generally oscillated below 1, suggesting the market valued the company's shares at less than their sales on a per share basis for most of the period. Notably, there was an extreme and likely erroneous spike in the ratio around 2023 which corresponds with the anomalous share price seen during the same period. Aside from this outlier, the P/S ratio tended to stabilize between approximately 0.4 and 0.8 towards the later years, reflecting a relatively consistent valuation metric compared to revenue per share.
Overall Insights
The data reflects steady growth in underlying business performance, as evidenced by continuous sales per share expansion. However, the market valuation in terms of share price and P/S ratio showed more volatility, potentially reflecting changing investor sentiment, market conditions, or data integrity issues. The sharp irregularities in 2023 warrant further investigation for confirmation or correction. Generally, the company's sales growth outpaced share price appreciation in many years, as shown by the generally sub-1 P/S ratio, indicating a conservative valuation relative to revenue.

Comparison to Competitors

Elevance Health Inc., P/S, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Elevance Health Inc., P/S, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)